Cent Eur J Public Health 2015, 23(3):223-226 | DOI: 10.21101/cejph.a4169

The Austrian Vaccination Paradox: Tick-borne Encephalitis Vaccination Versus Influenza Vaccination

Ursula Kunze, Michael Kunze
Centre for Public Health, Institute of Social Medicine, Medical University Vienna, Vienna, Austria

This paper describes a paradoxical situation in Austria. The vaccination rate against tick-borne encephalitis (TBE) in the general population is 82%, which is the highest worldwide, whereas the vaccination rate against influenza is about 8% and is among the lowest worldwide. A high awareness of TBE among the Austrian population achieved by an annual social marketing programme and the wide use of effective and well-tolerated vaccines have led to a successful containment of that disease. The vaccination coverage increased from 6% in 1980 to 82% in 2013 and exceeds 90% in some high-risk areas. This has led to a steady decline in the number of TBE cases from several hundred cases to 50 to 100 cases per year. The situation in regard to influenza vaccination is the opposite. Although Austria has issued one of the most extensive recommendations for influenza vaccination worldwide, the vaccination rate of the general population is extremely low. The possible reasons for the failure in the implementation of recommendations are ignorance, lack of social marketing and the predominance of a distinct discordance within the health system in general, and the Austrian medical fraternity in particular.

Keywords: tick-borne encephalitis, influenza, vaccination, vaccination coverage, Austria, epidemiology

Received: November 10, 2014; Revised: March 2, 2015; Accepted: March 2, 2015; Published: September 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Kunze U, Kunze M. The Austrian Vaccination Paradox: Tick-borne Encephalitis Vaccination Versus Influenza Vaccination. Cent Eur J Public Health. 2015;23(3):223-226. doi: 10.21101/cejph.a4169. PubMed PMID: 26615654.
Download citation

References

  1. Mansfield KL, Johnson N, Phipps LP, Stephenson JR, FooksAR, Solomon T. Tick-borne encephalitis virus - a review of an emerging zoonosis. J Gen Virol. 2009 Aug;90(Pt 8):1781-94. Go to original source... Go to PubMed...
  2. Thiel HJ, Collett MS, Gould EA, Heinz FX, Houghton M, Meyers G, et al. Flaviviridae. In: Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA, editors. Virus taxonomy: the eighth report of the International Committee on Taxonomy of Viruses. San Diego (CA): ElsevierAcademic Press; 2005. p. 981-98.
  3. Haglund M, Günther G. Tick-borne encephalitis - pathogenesis, clinical course and long-term follow-up. Vaccine. 2003 Apr 1;21 Suppl 1:S11-8. Go to original source... Go to PubMed...
  4. Bogovic P, Lotirc-Furlan S, Strle F. What tick-borne encephalitis may look like: clinical signs and symptoms. Travel Med Infect Dis. 2010 Jul;8(4):246-50. Go to original source... Go to PubMed...
  5. Donoso Mantke O, Schädler R, Niedrig M.Asurvey on cases of tick-borne encephalitis in European countries. Euro Surveill. 2008 Apr 24;13(17). pii: 18848. Go to original source...
  6. Donoso Mantke O, Escadafal C, Niedrig M, Pfeffer M; Working Group for Tick-borne Encephalitis Virus. Tick-borne encephalitis in Europe, 2007 to 2009. Euro Surveill. 2011 Sep 29;16(39). pii: 19976. Go to original source...
  7. Lundkvist A, Wallensten A, Vene S, Hjertqvist M. Tick-borne encephalitis increasing in Sweden, 2011. Euro Surveill. 2011 Sep 29;16(39). pii: 19981. Go to original source...
  8. Karelis G, Bormane A, Logina I, Lucenko I, Suna N, Krumina A, et al. Tick-borne encephalitis in Latvia 1973-2009: epidemiology, clinical features and sequelae. Eur J Neurol. 2012 Jan;19(1):62-8. Go to original source... Go to PubMed...
  9. Kunze U; ISWTBE. Tick-borne encephalitis: the impact of epidemiology, changing lifestyle, and environmental factors. Conference report of the 12th Annual Meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE). Vaccine. 2011 Feb 4;29(7):1355-6. Go to original source... Go to PubMed...
  10. Süss J. Epidemiology and ecology of TBE relevant to the production of effective vaccines. Vaccine. 2003 Apr 1;21 Suppl 1:S19-35. Go to original source... Go to PubMed...
  11. Vaccines against tick-borne encephalitis: WHO position paper. Wkly Epidemiol Rec. 2011 Jun 10;86(24):241-56. Go to PubMed...
  12. Fritz R, Orlinger KK, HofmeisterY, Janecki K, TrawegerA, Perez-Burgos L, et al. Quantitative comparison of the cross-protection induced by tickborne encephalitis virus vaccines based on European and Far Eastern virus subtypes. Vaccine. 2012 Feb 1;30(6):1165-9. Go to original source... Go to PubMed...
  13. Kunz C. TBE vaccination and the Austrian experience. Vaccine. 2003 Apr 1;21 Suppl 1:S50-5. Go to original source... Go to PubMed...
  14. GfK Healthcare. Population based representative survey - TBE vaccination status 2013. Vienna: GfK Austria Health Care; 2013.
  15. Heinz FX, Stiasny K, Holzmann H, Grgic-Vitek M, Kriz B, EsslA, Kundi M. Vaccination and tick-borne encephalitis, Central Europe. Emerg Infect Dis. 2013 Jan;19(1):69-76. Go to original source... Go to PubMed...
  16. World Health Organization. Influenza (Seasonal). Fact sheet No 211 [Internet]. Geneva: WHO; Mar 2014 [cited 2015 Feb 23].Available from: http://www.who.int/mediacentre/factsheets/fs211/en/.
  17. Bridges CB, Katz JM, Levandowski RA, Cox NJ. Inactivated influenza vaccines. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 5th ed. Philadelphia: Saunders Elsevier; 2008. p. 259-90. Go to original source...
  18. State of play on implementation of the Council Recommendation of 22 December 2009 on seasonal influenza vaccination (2009/1019/EU) [Internet]. Brussels: European Commission; Jan 2014 [cited 2015 Feb 23].Available from: http://ec.europa.eu/health/vaccination/docs/seasonflu_staffwd2014_en.pdf.
  19. Kuo HW, Schmid D, Liu YL, Lachner P,Allerberger F. Influenza-related excess mortality, Austria 2001 till 2009. Wien Klin Wochenschr. 2011 Oct;123(19-20):593-8. Go to original source... Go to PubMed...
  20. O'Flanagan D, Cotter S, Mereckiene J. Seasonal influenza vaccination in EU/EEA, influenza season 2011-12. Venice II Consortium. Septem ber 2012-February 2013 [Internet]. Roma: Istituto Superiore di Sanità; 2013 [cited 2015 Feb 23]. Available from: http://venice.cineca.org/VENICE_Seasonal_Influenza_2011-12_1.0v.pdf.
  21. European Centre for Disease Prevention and Control. Implementation of the Council Recommendation on seasonal influenza vaccination (2009/1019/EU). Stockholm: ECDC; 2014.
  22. Kunze U, Böhm G, Groman E. Influenza vaccination in Austria from 1982 to 2011: a country resistant to influenza prevention and control. Vaccine. 2013 Oct 17;31(44):5099-103. Go to original source... Go to PubMed...
  23. Kunze M. The contribution of social medicine to vaccination in Austria. Wien Med Wochenschr. 1998;148(8-9):191-7. (In German.) Go to PubMed...
  24. Blank PR, Szucs TD. Increasing influenza vaccination coverage in recommended population groups in Europe. Expert Rev Vaccines. 2009 Apr;8(4):425-33. Go to original source... Go to PubMed...
  25. Blank PR, Schwenkglenks M, Szucs TD. The impact of European vaccination policies on seasonal influenza vaccination coverage rates in the elderly. Hum Vaccin Immunother. 2012 Mar;8(3):328-35. Go to original source... Go to PubMed...
  26. Endrich MM, Blank PR, Szucs TD. Influenza vaccination uptake and socioeconomic determinants in 11 European countries. Vaccine. 2009 Jun 19;27(30):4018-24. Go to original source... Go to PubMed...
  27. Wortberg S, Walter D, Knesbeck M, Reiter S. Physicians as key communicators of the influenza vaccination for the elderly, patients with chronic conditions, and health care workers. Results of a nationwide survey in the context of the national influenza vaccination campaign. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2009 Oct;52(10):945-52. (In German.) Go to original source... Go to PubMed...
  28. Blank PR, Schwenkglenks M, Szucs TD. Vaccination coverage rates in eleven European countries during two consecutive influenza seasons. J Infect. 2009 Jun;58(6):446-58. Go to original source... Go to PubMed...
  29. Kroneman M, van Essen GA, John Paget W. Influenza vaccination coverage and reasons to refrain among high-risk persons in four European countries. Vaccine. 2006 Jan 30;24(5):622-8. Go to original source... Go to PubMed...
  30. Flood EM, Rousculp MD, Ryan KJ, Beusterien KM, Divino VM, Toback SL, et al. Parents' decision-making regarding vaccinating their children against influenza: a web-based survey. Clin Ther. 2010Aug;32(8):144867. Go to original source... Go to PubMed...
  31. Baykan Z, Naçar M, Özdemir SB, Poyrazoğlu S, Çetinkaya F. Knowledge and attitude of family physicians regarding adult vaccination. World J Vaccines. 2011 Aug;1(3):92-7. Go to original source...
  32. Clark J. Five futures for academic medicine: the ICRAM scenarios. BMJ. 2005 Jul 9;331(7508):101-4. Go to original source...
  33. European Centre for Disease Prevention and Control. Review of scientific literature on drivers and barriers of seasonal influenza vaccination coverage in the EU/EEA. Stockholm: ECDC; 2013.